Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Garikapati Koteswara Rao"'
Autor:
Khan, Irfan, Garikapati, Koteswara Rao, Setti, Aravind, Shaik, Anver Basha, Kanth Makani, Venkata Krishna, Shareef, Mohd Adil, Rajpurohit, Hemshikha, Vangara, Namratha, Pal-Bhadra, Manika, Kamal, Ahmed, Kumar, C. Ganesh
Publikováno v:
In European Journal of Medicinal Chemistry 1 February 2019 163:636-648
Autor:
Khan, Irfan, Garikapati, Koteswara Rao, Shaik, Anver Basha, Makani, Venkata Krishna Kanth, Rahim, Abdul, Shareef, Mohd Adil, Reddy, V. Ganga, Pal-Bhadra, Manika, Kamal, Ahmed, Kumar, C. Ganesh
Publikováno v:
In European Journal of Medicinal Chemistry 20 January 2018 144:104-115
Autor:
Patel, Nibedita, Garikapati, Koteswara Rao, Ramaiah, M. Janaki, Polavarapu, Kavi Kishor, Bhadra, Utpal, Bhadra, Manika Pal
Publikováno v:
In Life Sciences 1 November 2016 164:60-70
Autor:
Utpal Bhadra, Garikapati Koteswara Rao, Maresha Ramakrishna, Jolly Janette Mendonza, Manika Pal Bhadra, Jayashree Chiring Phukon, Venkata Krishna Kanth Makani, Nibedita Patel, Jedy Jose, Priyanka Cilamkoti, Prajitha Mohandas Edathara
Publikováno v:
The FEBS Journal. 289:2915-2934
Brother of Regulator of Imprinted Sites (BORIS) or CCCTC-Binding Factor Like (CTCFL) is a nucleotide-binding protein, aberrantly expressed in various malignancies. Expression of BORIS has been found to be associated with the expression of oncogenes w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ba0fd41d7d26e76c1c08e45a9474383
https://doi.org/10.1111/febs.16309
https://doi.org/10.1111/febs.16309
Autor:
Chandrakant Bagul, Garikapati Koteswara Rao, Immadi Veena, Ravindra Kulkarni, Jaki R. Tamboli, Ravikumar Akunuri, Siddiq Pasha Shaik, Manika Pal-Bhadra, Ahmed Kamal
Publikováno v:
Molecular diversity.
A library of benzimidazole briged pyrazolo[1,5-a]pyrimidine (6a-q) was designed, synthesized and subjected for evaluation for cytotoxic potential. Antiproliferative activity, ranging from 3.1-51.5 μM, was observed against a panel of cancer cell line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12319ae0a6c3da01e94167ddb1b5f1de
https://pubmed.ncbi.nlm.nih.gov/36114912
https://pubmed.ncbi.nlm.nih.gov/36114912
Autor:
Patel, Nibedita1, Garikapati, Koteswara Rao1,2, Makani, Venkata Krishna Kanth1, Nair, Ayikkara Drishya1, Vangara, Namratha1, Bhadra, Utpal3, Pal Bhadra, Manika1 manikapb@gmail.com
Publikováno v:
PLoS ONE. 2/2/2018, Vol. 13 Issue 2, p1-22. 22p.
Autor:
Manika Pal-Bhadra, Venkata Krishna Kanth Makani, Chandrakant Bagul, Jaki R. Tamboli, Garikapati Koteswara Rao, Ahmed Kamal
Publikováno v:
MedChemComm. 8:1810-1816
A series of pyrazolo[1,5-a]pyrimidines substituted at C5 with 1-phenylprop-2-en-1-one (6a-q) and 3-phenylprop-2-en-1-one (7a-k) was synthesized and evaluated for antiproliferative activity. Among them, 6h was found to be the most active compound agai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::590d56e8abb4d0f7ecb19d479f29cf41
https://doi.org/10.1039/c7md00193b
https://doi.org/10.1039/c7md00193b
Autor:
Garikapati Koteswara Rao, Ahmed Kamal, Sunitha Rani Routhu, Aarti Juvekar, Vangala Santhosh Reddy, Immadi Veena, Shailesh Jadhav, Madan Barkume, Nibedita Patel, Anver Basha Shaik, Irfan Khan, Kunta Chandra Shekar, C. Ganesh Kumar, Manika Pal-Bhadra, G. Bharath Kumar, Jyoti Kode
Publikováno v:
European journal of medicinal chemistry. 139
Cancer has been established as the "Emperor of all maladies". In recent years, medicinal chemistry has focused on identifying novel anti-cancer compounds; though discovery of these compounds appears to be a herculean task. In present study, we synthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89764c79ff896ed2390a72a33e3a7fc1
https://pubmed.ncbi.nlm.nih.gov/28803046
https://pubmed.ncbi.nlm.nih.gov/28803046
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.